AU2002222138A1 - Drug delivery system - Google Patents

Drug delivery system

Info

Publication number
AU2002222138A1
AU2002222138A1 AU2002222138A AU2213802A AU2002222138A1 AU 2002222138 A1 AU2002222138 A1 AU 2002222138A1 AU 2002222138 A AU2002222138 A AU 2002222138A AU 2213802 A AU2213802 A AU 2213802A AU 2002222138 A1 AU2002222138 A1 AU 2002222138A1
Authority
AU
Australia
Prior art keywords
delivery system
drug delivery
drug
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002222138A
Other languages
English (en)
Inventor
Susan A. Barker
Duncan Craig
Assoc Prof. Dr Kah Hay Yuen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Queens University of Belfast
Original Assignee
Queens University of Belfast
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queens University of Belfast filed Critical Queens University of Belfast
Publication of AU2002222138A1 publication Critical patent/AU2002222138A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2002222138A 2000-12-07 2001-12-07 Drug delivery system Abandoned AU2002222138A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0029843.0A GB0029843D0 (en) 2000-12-07 2000-12-07 Drug delivery system
GB0029843 2000-12-07
PCT/GB2001/005420 WO2002045696A1 (fr) 2000-12-07 2001-12-07 Systeme d'administration de medicament

Publications (1)

Publication Number Publication Date
AU2002222138A1 true AU2002222138A1 (en) 2002-06-18

Family

ID=9904621

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002222138A Abandoned AU2002222138A1 (en) 2000-12-07 2001-12-07 Drug delivery system

Country Status (3)

Country Link
AU (1) AU2002222138A1 (fr)
GB (1) GB0029843D0 (fr)
WO (1) WO2002045696A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
DE10341043A1 (de) * 2003-09-03 2005-03-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue oral zu applizierende Darreichungsform für 3-[(2-{[4-Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester und dessen Salze
GB2451811A (en) 2007-08-09 2009-02-18 Ems Sa Delivery composition for solubilising water-insoluble pharmaceutical active ingredients
CN109512787A (zh) * 2018-12-07 2019-03-26 天津国际生物医药联合研究院 一种维生素b12固体分散体及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1191608B (it) * 1985-02-01 1988-03-23 Zambon Spa Composizione farmaceutica e forme farmaceutiche che la contengono
US5993858A (en) * 1996-06-14 1999-11-30 Port Systems L.L.C. Method and formulation for increasing the bioavailability of poorly water-soluble drugs

Also Published As

Publication number Publication date
WO2002045696A1 (fr) 2002-06-13
GB0029843D0 (en) 2001-01-24

Similar Documents

Publication Publication Date Title
AU2001288388A1 (en) Substance delivery system
AU2001264887A1 (en) Drug delivery device
AU2001235009A1 (en) Drug delivery apparatus
AU2001238386A1 (en) Medication delivery devices
AU2123200A (en) Drug delivery device
AU4985600A (en) Drug delivery device
HUP0401438A3 (en) Drug delivery system
IL155272A0 (en) Systems for optimized drug delivery
AU2002244142A1 (en) Integrated medication delivery system
AU2001283359A1 (en) Drug release (delivery system)
AU4947100A (en) Drug delivery device
AU2002343555A1 (en) Eutectic-based self-nanoemulsified drug delivery system
HK1077523A1 (en) Proliposomal drug delivery system
AU2001281171A1 (en) Medication dispensing system
AUPR573001A0 (en) Lymphatic drug delivery system
AU2001270963A1 (en) Transdermal drug delivery system
AU2001260244A1 (en) Product delivery system
AU2002222138A1 (en) Drug delivery system
AU2002210580A1 (en) Drug delivery system
AU2001244854A1 (en) Local drug delivery
AUPR146700A0 (en) Drug delivery system
AU2002218904A1 (en) Pharmaceutical delivery system
AU2001238040A1 (en) Offer delivery system
AU4808000A (en) Drug delivery system
AU2002228323A1 (en) Spaced drug delivery system